476474-11-0
476474-11-0
Chemical Structure
TGF-βRI inhibitor 2
- CAS No.: 476474-11-0
- Formula:C20H16N4O
- Molecular Weight:328.37
IUPAC Name: 4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol
InChIKey: ZDNICFYNWASODE-UHFFFAOYSA-N
SMILES: OC1=CC=C2C(C(C(C3=CC=CC=N3)=N4)=C5N4CCC5)=CC=NC2=C1
Biological Activity: TGF-βRI inhibitor 2 (compound 13) is a TGF-βRI inhibitor. TGF-βRI inhibitor 2 can be used in cancer research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TGF-βRI inhibitor 2 | 98.32% | TGF-βRI inhibitor 2 (compound 13) is a TGF-βRI inhibitor. TGF-βRI inhibitor 2 can be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Li HY, et al. Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent. J Med Chem. 2008 Apr 10;51(7):2302-6. [Content Brief]
Keywords
